The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7-(6-(4-Isopropylpiperazin-1-yl)pyridin-3-yl)-N-((6-methyl-2-oxo-4-propyl-1,2-dihydropyridin-3-yl)methyl)pyrazolo[1,5-a]pyridine-3-carboxamide ID: ALA4538395
PubChem CID: 155548857
Max Phase: Preclinical
Molecular Formula: C30H37N7O2
Molecular Weight: 527.67
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCCc1cc(C)[nH]c(=O)c1CNC(=O)c1cnn2c(-c3ccc(N4CCN(C(C)C)CC4)nc3)cccc12
Standard InChI: InChI=1S/C30H37N7O2/c1-5-7-22-16-21(4)34-30(39)24(22)18-32-29(38)25-19-33-37-26(8-6-9-27(25)37)23-10-11-28(31-17-23)36-14-12-35(13-15-36)20(2)3/h6,8-11,16-17,19-20H,5,7,12-15,18H2,1-4H3,(H,32,38)(H,34,39)
Standard InChI Key: ICSYYXXEHVPUOX-UHFFFAOYSA-N
Molfile:
RDKit 2D
39 43 0 0 0 0 0 0 0 0999 V2000
12.7387 -7.6609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1473 -8.3700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7387 -9.0791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9215 -9.0791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5130 -8.3700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9215 -7.6609 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.6669 -6.8837 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.3301 -6.4036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9893 -6.8837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7665 -6.6332 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9373 -5.8348 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.3739 -7.1804 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.0874 -6.7769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5010 -6.7905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7915 -7.1930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7811 -8.0087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4853 -8.4248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1998 -8.0253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2052 -7.2066 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.0716 -8.4112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0612 -9.2268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7654 -9.6430 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5114 -5.9749 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.9040 -8.4414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2872 -9.0791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6958 -8.3700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2872 -7.6609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4700 -7.6609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0614 -8.3700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4700 -9.0791 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.2442 -8.3700 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.8356 -7.6609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0184 -7.6609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6098 -8.3700 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.0184 -9.0791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8356 -9.0791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7926 -8.3700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3840 -7.6609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3840 -9.0791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
1 6 1 0
7 8 2 0
8 9 1 0
6 7 1 0
1 9 2 0
10 11 2 0
10 12 1 0
9 10 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
14 19 1 0
20 21 1 0
21 22 1 0
16 20 1 0
14 23 2 0
18 24 1 0
13 15 1 0
12 13 1 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 30 1 0
25 30 2 0
31 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
35 36 1 0
31 36 1 0
37 38 1 0
37 39 1 0
34 37 1 0
29 31 1 0
5 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 527.67Molecular Weight (Monoisotopic): 527.3009AlogP: 3.81#Rotatable Bonds: 8Polar Surface Area: 98.63Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 11.63CX Basic pKa: 8.03CX LogP: 3.23CX LogD: 2.51Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.36Np Likeness Score: -1.66
References 1. Yang X, Li F, Konze KD, Meslamani J, Ma A, Brown PJ, Zhou MM, Arrowsmith CH, Kaniskan HÜ, Vedadi M, Jin J.. (2016) Structure-Activity Relationship Studies for Enhancer of Zeste Homologue 2 (EZH2) and Enhancer of Zeste Homologue 1 (EZH1) Inhibitors., 59 (16): [PMID:27468126 ] [10.1021/acs.jmedchem.6b00855 ]